Compare CSX & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSX | IDXX |
|---|---|---|
| Founded | 1978 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Railroads | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.5B | 57.1B |
| IPO Year | N/A | 1991 |
| Metric | CSX | IDXX |
|---|---|---|
| Price | $40.74 | $628.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 9 |
| Target Price | $38.24 | ★ $715.00 |
| AVG Volume (30 Days) | ★ 15.2M | 540.3K |
| Earning Date | 01-22-2026 | 02-02-2026 |
| Dividend Yield | ★ 1.28% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | 1.54 | ★ 13.08 |
| Revenue | ★ $14,092,000,000.00 | $4,303,702,000.00 |
| Revenue This Year | $3.78 | $10.63 |
| Revenue Next Year | $4.59 | $8.91 |
| P/E Ratio | ★ $26.43 | $47.19 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $26.22 | $356.14 |
| 52 Week High | $41.79 | $769.98 |
| Indicator | CSX | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 67.61 | 34.13 |
| Support Level | $36.56 | $629.73 |
| Resistance Level | $41.79 | $651.57 |
| Average True Range (ATR) | 0.82 | 18.47 |
| MACD | 0.21 | -3.46 |
| Stochastic Oscillator | 71.79 | 21.50 |
Operating in the Eastern United States, Class I railroad CSX generated revenue near $14.5 billion in 2024. On its more than 21,000 miles of track, CSX hauls shipments of coal (16% of consolidated revenue), chemicals (17%), intermodal containers (16%), automotive cargo (7%), and a diverse mix of other bulk and industrial merchandise.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.